vs
Side-by-side financial comparison of DOMO, INC. (DOMO) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
DOMO, INC. is the larger business by last-quarter revenue ($79.4M vs $75.5M, roughly 1.1× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -0.5%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $1.1M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -0.5%).
Domo, Inc. is an American cloud software company based in American Fork, Utah, United States. It specializes in artificial intelligence, business intelligence, and data visualization and is designed to provide real-time access to business data for decision makers across the company with minimal IT involvement. It is a Software-as-a-Service (SaaS) venture.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
DOMO vs PBYI — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $79.4M | $75.5M |
| Net Profit | $-10.4M | — |
| Gross Margin | 74.2% | 69.3% |
| Operating Margin | -8.7% | 22.7% |
| Net Margin | -13.1% | — |
| Revenue YoY | -0.5% | 27.7% |
| Net Profit YoY | 44.6% | — |
| EPS (diluted) | $-0.25 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $79.4M | $75.5M | ||
| Q3 25 | $79.7M | $54.5M | ||
| Q2 25 | $80.1M | $52.4M | ||
| Q1 25 | $78.8M | $46.0M | ||
| Q4 24 | $79.8M | $59.1M | ||
| Q3 24 | $78.4M | $80.5M | ||
| Q2 24 | $80.1M | $47.1M | ||
| Q1 24 | $80.2M | $43.8M |
| Q4 25 | $-10.4M | — | ||
| Q3 25 | $-22.9M | $8.8M | ||
| Q2 25 | $-18.1M | $5.9M | ||
| Q1 25 | $-17.7M | $3.0M | ||
| Q4 24 | $-18.8M | — | ||
| Q3 24 | $-19.5M | $20.3M | ||
| Q2 24 | $-26.0M | $-4.5M | ||
| Q1 24 | $-18.7M | $-4.8M |
| Q4 25 | 74.2% | 69.3% | ||
| Q3 25 | 74.8% | 77.7% | ||
| Q2 25 | 74.2% | 76.5% | ||
| Q1 25 | 74.4% | 77.1% | ||
| Q4 24 | 75.0% | 76.4% | ||
| Q3 24 | 74.3% | 63.9% | ||
| Q2 24 | 74.1% | 77.4% | ||
| Q1 24 | 76.3% | 75.5% |
| Q4 25 | -8.7% | 22.7% | ||
| Q3 25 | -9.1% | 17.6% | ||
| Q2 25 | -17.9% | 12.7% | ||
| Q1 25 | -15.6% | 8.7% | ||
| Q4 24 | -13.9% | 22.6% | ||
| Q3 24 | -18.5% | 27.4% | ||
| Q2 24 | -26.8% | -4.6% | ||
| Q1 24 | -16.6% | -5.3% |
| Q4 25 | -13.1% | — | ||
| Q3 25 | -28.8% | 16.2% | ||
| Q2 25 | -22.5% | 11.2% | ||
| Q1 25 | -22.4% | 6.5% | ||
| Q4 24 | -23.5% | — | ||
| Q3 24 | -24.9% | 25.2% | ||
| Q2 24 | -32.5% | -9.6% | ||
| Q1 24 | -23.3% | -11.0% |
| Q4 25 | $-0.25 | $0.26 | ||
| Q3 25 | $-0.56 | $0.17 | ||
| Q2 25 | $-0.45 | $0.12 | ||
| Q1 25 | $-0.45 | $0.06 | ||
| Q4 24 | $-0.48 | $0.40 | ||
| Q3 24 | $-0.51 | $0.41 | ||
| Q2 24 | $-0.69 | $-0.09 | ||
| Q1 24 | $-0.51 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $97.5M |
| Total DebtLower is stronger | $124.2M | $22.7M |
| Stockholders' EquityBook value | $-191.9M | $130.3M |
| Total Assets | $201.6M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | $47.2M | $96.0M | ||
| Q1 25 | $45.3M | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | $61.2M | $96.8M | ||
| Q1 24 | $60.9M | $107.2M |
| Q4 25 | $124.2M | $22.7M | ||
| Q3 25 | $121.9M | $34.0M | ||
| Q2 25 | $119.7M | $45.3M | ||
| Q1 25 | $117.7M | $56.7M | ||
| Q4 24 | $115.6M | $68.0M | ||
| Q3 24 | $115.2M | $79.3M | ||
| Q2 24 | $114.1M | $90.7M | ||
| Q1 24 | $113.5M | $102.0M |
| Q4 25 | $-191.9M | $130.3M | ||
| Q3 25 | $-191.5M | $115.3M | ||
| Q2 25 | $-178.7M | $104.7M | ||
| Q1 25 | $-177.2M | $97.1M | ||
| Q4 24 | $-171.2M | $92.1M | ||
| Q3 24 | $-166.4M | $71.1M | ||
| Q2 24 | $-163.5M | $48.5M | ||
| Q1 24 | $-153.5M | $51.0M |
| Q4 25 | $201.6M | $216.3M | ||
| Q3 25 | $195.7M | $202.9M | ||
| Q2 25 | $189.7M | $194.9M | ||
| Q1 25 | $214.3M | $196.2M | ||
| Q4 24 | $190.2M | $213.3M | ||
| Q3 24 | $197.8M | $220.7M | ||
| Q2 24 | $204.4M | $205.0M | ||
| Q1 24 | $225.7M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $3.4M | $14.4M |
| Free Cash FlowOCF − Capex | $1.1M | $14.4M |
| FCF MarginFCF / Revenue | 1.4% | 19.1% |
| Capex IntensityCapex / Revenue | 2.9% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $9.9M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.4M | $14.4M | ||
| Q3 25 | $3.4M | $9.7M | ||
| Q2 25 | $4.0M | $14.1M | ||
| Q1 25 | $8.9M | $3.6M | ||
| Q4 24 | $-13.7M | $15.6M | ||
| Q3 24 | $-6.2M | $11.0M | ||
| Q2 24 | $1.9M | $1.0M | ||
| Q1 24 | $5.4M | $11.2M |
| Q4 25 | $1.1M | $14.4M | ||
| Q3 25 | $1.0M | $9.7M | ||
| Q2 25 | $1.0M | $14.1M | ||
| Q1 25 | $6.7M | $3.6M | ||
| Q4 24 | $-16.2M | $15.6M | ||
| Q3 24 | $-8.4M | $11.0M | ||
| Q2 24 | $-625.0K | $1.0M | ||
| Q1 24 | $2.9M | — |
| Q4 25 | 1.4% | 19.1% | ||
| Q3 25 | 1.3% | 17.7% | ||
| Q2 25 | 1.3% | 26.8% | ||
| Q1 25 | 8.5% | 7.7% | ||
| Q4 24 | -20.3% | 26.4% | ||
| Q3 24 | -10.7% | 13.7% | ||
| Q2 24 | -0.8% | 2.1% | ||
| Q1 24 | 3.6% | — |
| Q4 25 | 2.9% | 0.0% | ||
| Q3 25 | 2.9% | 0.0% | ||
| Q2 25 | 3.7% | 0.0% | ||
| Q1 25 | 2.8% | 0.1% | ||
| Q4 24 | 3.2% | 0.0% | ||
| Q3 24 | 2.8% | 0.0% | ||
| Q2 24 | 3.2% | 0.0% | ||
| Q1 24 | 3.1% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOMO
| Subscription | $71.9M | 91% |
| Professional Servicesand Other | $7.5M | 9% |
PBYI
Segment breakdown not available.